The latest thoracic oncology news
Mayo clinic study suggests patients with lung cancer be screened for MET oncogene
Research by investigators at Mayo Clinic Cancer Center (USA) suggests that physicians should screen patients…
Browsing: Lung Cancer
Loss of circadian regulation allows for increase in glucose production during lung cancer
New research from the University of California, Irvine, USA< reveals how the circadian regulation of…
The OJC Episode 37: ASCO 2021 Lung Cancer Roundtable
The Oncology Journal Club Podcast Episode 37: Listen here In today’s special ASCO 2021 episode…
ASCO 2021: Newly approved drug effective against lung cancer caused by genetic mutation
The new drug sotorasib reduces tumour size and shows promise in improving survival among patients…
Research suggests BMI may not be best obesity indicator to assess risk for lung cancer
New research published in the Journal of Thoracic Oncology (JTO) suggests the method used to calculate how…
Delaying lung cancer surgery associated with higher risk of recurrence, death
Swiftness is essential when treating lung cancer, the second most common type of cancer in…
ASCO 2021: Immunotherapy delays disease recurrence in patients with early-stage, resected non-small cell lung cancer
“For the first time, we are seeing that an immunotherapy is effective when used to…
ASCO 2021: Antibody drug conjugate shows promise against non-small cell lung cancer resistant to targeted therapy
An antibody fused to a targeted drug has produced impressive results in a Phase I…
Researchers identify potential combination therapy for aggressive lung cancer
A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, has identified…
Age-related muscle loss and walking abilities predict outcomes after lung cancer surgery
Lung cancer is a major global cause of mortality, reportedly accounting for 1.7 million deaths…